Expression of Interferon Lambda 4 Is Associated with Reduced Proliferation and Increased Cell Death in Human Hepatic Cells
Overview
Authors
Affiliations
Interferon lambda 4 (IFN-λ4) is a novel type-III interferon that can be generated only in individuals carrying a ΔG frame-shift allele of an exonic genetic variant (rs368234815-ΔG/TT). The rs368234815-ΔG allele is strongly associated with decreased clearance of hepatitis C virus (HCV) infection. Here, we further explored the biological function of IFN-λ4 expressed in human hepatic cells-a hepatoma cell line HepG2 and fresh primary human hepatocytes (PHHs). We performed live confocal imaging, cell death and proliferation assays, mRNA expression profiling, protein detection, and antibody blocking assays using transient and inducible stable in vitro systems. Not only did we observe significant intracellular retention of IFN-λ4 but also detected secreted IFN-λ4 in the culture media of expressing cells. Secreted IFN-λ4 induced strong activation of the interferon-stimulated genes (ISGs) in IFN-λ4-expressing and surrounding cells in transwell assays. Specifically, in PHHs, secreted IFN-λ4 induced expression of the CXCL10 transcript and a corresponding pro-inflammatory chemokine, IP-10. In IFN-λ4-expressing HepG2 cells, we also observed decreased proliferation and increased cell death. All IFN-λ4-induced phenotypes--activation of ISGs, decreased proliferation, and increased cell death--could be inhibited by an anti-IFN-λ4-specific antibody. Our study offers new insights into biology of IFN-λ4 and its possible role in HCV clearance.
Structural studies of the IFNλ4 receptor complex using cryoEM enabled by protein engineering.
Grubbe W, Zhang B, Kauffman A, Bylehn F, Padol K, Jung H Nat Commun. 2025; 16(1):818.
PMID: 39827213 PMC: 11742915. DOI: 10.1038/s41467-025-56119-y.
Martinez-Espinoza I, Guerrero-Plata A Immunohorizons. 2023; 7(4):265-272.
PMID: 37071039 PMC: 10579847. DOI: 10.4049/immunohorizons.2200010.
Onabajo O, Wang F, Lee M, Florez-Vargas O, Obajemu A, Tanikawa C Front Immunol. 2021; 12:692263.
PMID: 34497603 PMC: 8419317. DOI: 10.3389/fimmu.2021.692263.
Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses.
Chen Q, Coto-Llerena M, Suslov A, Teixeira R, Fofana I, Nuciforo S Nat Commun. 2021; 12(1):4882.
PMID: 34385466 PMC: 8360984. DOI: 10.1038/s41467-021-25218-x.
Double-edged effects of interferons on the regulation of cancer-immunity cycle.
Zhang X, Wang S, Zhu Y, Zhang M, Zhao Y, Yan Z Oncoimmunology. 2021; 10(1):1929005.
PMID: 34262796 PMC: 8253121. DOI: 10.1080/2162402X.2021.1929005.